NASDAQ:MDAI - US84757T1051 - Common Stock
The current stock price of MDAI is 1.86 USD. In the past month the price decreased by -23.77%. In the past year, price increased by 44.19%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 26.95 | 229.81B | ||
ISRG | INTUITIVE SURGICAL INC | 58.32 | 168.28B | ||
BSX | BOSTON SCIENTIFIC CORP | 38.24 | 160.35B | ||
SYK | STRYKER CORP | 30.51 | 149.86B | ||
MDT | MEDTRONIC PLC | 16.7 | 118.47B | ||
BDX | BECTON DICKINSON AND CO | 13.36 | 54.66B | ||
IDXX | IDEXX LABORATORIES INC | 54.4 | 52.27B | ||
EW | EDWARDS LIFESCIENCES CORP | 31.07 | 46.88B | ||
RMD | RESMED INC | 29.17 | 40.79B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 16.62 | 35.37B | ||
DXCM | DEXCOM INC | 46.41 | 30.94B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 16.56 | 26.79B |
Spectral AI, Inc. is a predictive artificial intelligence company. The company is headquartered in Dallas, Texas and currently employs 78 full-time employees. The company went IPO on 2021-02-12. The firm's DeepView platform is a predictive device that offers clinicians an objective and immediate assessment of a wound healing potential prior to treatment or other medical intervention. DeepView platform that combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential. The company is non-invasive, non-radiation, non-laser and does not require the use of injectable dye. The DeepView AI- Burn software is used with the DeepView SnapShot imaging device, and it is intended to be used as an adjunctive tool to aid healthcare providers in the assessment of burn wound healing potential by differentiating non-healing from healing burned tissue within an image.
SPECTRAL AI INC
2515 McKinney Avenue, Suite 1000
Dallas TEXAS US
Employees: 78
Phone: 12124923000
The current stock price of MDAI is 1.86 USD. The price increased by 2.2% in the last trading session.
The exchange symbol of SPECTRAL AI INC is MDAI and it is listed on the Nasdaq exchange.
MDAI stock is listed on the Nasdaq exchange.
9 analysts have analysed MDAI and the average price target is 4.96 USD. This implies a price increase of 166.65% is expected in the next year compared to the current price of 1.86. Check the SPECTRAL AI INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
SPECTRAL AI INC (MDAI) has a market capitalization of 49.72M USD. This makes MDAI a Nano Cap stock.
SPECTRAL AI INC (MDAI) currently has 78 employees.
SPECTRAL AI INC (MDAI) has a support level at 1.81 and a resistance level at 1.87. Check the full technical report for a detailed analysis of MDAI support and resistance levels.
The Revenue of SPECTRAL AI INC (MDAI) is expected to decline by -24.9% in the next year. Check the estimates tab for more information on the MDAI EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
MDAI does not pay a dividend.
SPECTRAL AI INC (MDAI) will report earnings on 2025-11-04, after the market close.
SPECTRAL AI INC (MDAI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.69).
The outstanding short interest for SPECTRAL AI INC (MDAI) is 4.74% of its float. Check the ownership tab for more information on the MDAI short interest.
ChartMill assigns a technical rating of 2 / 10 to MDAI. When comparing the yearly performance of all stocks, MDAI is one of the better performing stocks in the market, outperforming 79.05% of all stocks.
ChartMill assigns a fundamental rating of 1 / 10 to MDAI. MDAI may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months MDAI reported a non-GAAP Earnings per Share(EPS) of -0.69. The EPS increased by 54.76% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -89.41% | ||
ROE | N/A | ||
Debt/Equity | N/A |
9 analysts have analysed MDAI and the average price target is 4.96 USD. This implies a price increase of 166.65% is expected in the next year compared to the current price of 1.86.
For the next year, analysts expect an EPS growth of 53.25% and a revenue growth -24.9% for MDAI